We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

By LabMedica International staff writers
Posted on 05 Jun 2025

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable. More...

While cancer cell migration plays a central role in metastasis, tracking how cells receive and respond to movement-regulating signals has proven difficult. Now, a newly developed fluorescent probe is helping researchers visualize these signaling dynamics in real time, offering a promising pathway for therapeutic intervention to limit cancer spread.

The study was conducted by researchers at the University of Turku (Turku, Finland), whose work focuses on identifying molecular factors that regulate the metastatic behavior of breast cancer cells. Their recent findings center on the role of the protein phosphatase Shp2—short for “Ship two”—which emerged as a critical regulator of metastasis by influencing how cancer cells interact with surrounding tissues. Using their new fluorescent probe, the research team was able to observe how cancer cells process external signals during migration. The probe highlights real-time signaling events within moving cells, making it possible to monitor the dynamics that drive metastasis. This innovation provided the researchers with deeper insight into Shp2’s function and its role in promoting the invasive capabilities of breast cancer cells.

The team’s study also revealed that certain drugs already in clinical trials for other tumor types could be repurposed to inhibit breast cancer metastasis by targeting Shp2-mediated signaling. While these findings are specific to breast cancer, the researchers believe the implications extend to understanding invasion mechanisms in other solid tumors. The work not only introduces a powerful tool for studying cancer cell movement but also opens up new avenues for potential treatment strategies. The researchers are now actively pursuing therapeutic applications based on these results. The implications of this discovery extend beyond breast cancer alone and may help understand cancer cell invasion from solid tumors more generally.

"Researchers develop color-based probes to detect different events in live cells, but this type of cell-dynamics reporter had not been available before. It has transformed our understanding of what sorts of signaling are needed for cell movement,” said Dr. James Conway, the lead researcher of the team. “These probes often take on names from pop culture references. The lab came up with the name Illusia, drawing from an old Finnish story about a fairy that comes to earth from the rainbow. This gave our work a colorful twist, something we are all seeking in today’s world, as we strive for better treatments.”

Related Links:
University of Turku 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.